Adam Mishler
Analyst
Translational and Research Lead, DMD Program
Equibles does not estimate personal net worth.
About Adam Mishler
Adam Mishler is recorded as Analyst at Translational and Research Lead, DMD Program. Adam Mishler has spoken on 1 investor event across 1 company, most recently for Precision Biosciences Inc on June 3, 2026. The companies whose calls Adam Mishler spoke on are classified in the Healthcare sector.
Adam Mishler on recent calls
“So we're creating one of the most functional dystrophin proteins that hasn't been seen with the gene therapies today. We've shown preclinically that we're able to produce up to 35% dystrophin and up to 85% of the cells overall.”
Affiliation history
-
Translational and Research Lead, DMD Program
Analyst
Transcript header (unverified)
Current